OncoDiag
Latest round
- Series A
Last raised
- Feb 2021
Total raised
- $1.8M
Investors
- 7
About OncoDiag
Founded in 2013 in France, OncoDiag focuses on developing cancer diagnostic solutions.OncoDiag specializes in innovative cancer diagnostic solutions, offering a suite of lab tests designed to facilitate the early detection and monitoring of various cancers. Their primary products include Urodiag®, a CE-IVD certified urine-based test aimed at the surveillance of bladder cancer; Prostadiag®, a tissue-based test that predicts non-evolutive localized prostate cancer; and Colodiag®, which is a blood-based test for the screening of colorectal cancer. These products address critical clinical needs such as early detection, patient monitoring, and risk assessment, aiding healthcare professionals in making informed treatment decisions.OncoDiag's revenue model is structured around B2B transactions, involving partnerships with healthcare institutions and laboratories that utilize their diagnostic tests. Revenue is derived from the sale of their flagship products, including Urodiag®, Prostadiag®, and Colodiag®, through direct sales agreements or distribution partnerships, ensuring accessibility in diagnostic settings. The company is actively working on launching additional tests aimed at improving cancer detection capabilities over the next two years. Additionally, OncoDiag seeks to expand its operations into new European markets, targeting regions such as Germany and the Benelux countries by 2023.
Who invested in OncoDiag
7 investors across 1 round
See all investors in OncoDiag
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 18, 2021
Amount
$1.8M
Investors
Questions about OncoDiag
Who invested in OncoDiag?
OncoDiag has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OncoDiag raised?
OncoDiag has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did OncoDiag last raise money?
OncoDiag's most recent round on record is a Series A, in Feb 2021.
What does OncoDiag do?
Founded in 2013 in France, OncoDiag focuses on developing cancer diagnostic solutions.
Where is OncoDiag headquartered?
OncoDiag is headquartered in France.
Which VCs invest in companies like OncoDiag?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at OncoDiag's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like OncoDiag? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.